A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Results first posted: Jun 22, 2026v5 Show 6 more changesShow less
    • Primary endpoints: 2 to 1
    • Enrollment target: estimated 212 to confirmed 169
    • Primary completion date: Jul 2007
    • Interventions: Consultation with Endocrinologist (Behavioral), Counseling from Diabetes Educator (Behavioral), Counseling from Dietician (Behavioral) to Consultation with Endocrinologist (Behavioral), Counseling from Diabetes Educator (Behavioral), Counseling from Dietician (Behavioral), No…
    • Secondary endpoints shortened, about 176 words
    • Study arms: 0 to 2
  2. Minor Trial status: Recruiting to Completed
    • Study completion date changed from estimate of Aug 2007 to Oct 2007
    • Site details revised
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Notable Primary endpoints revised (2)
    • Secondary endpoints revised (14)
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
8,844 trials monitored
See 432 trials at risk
5,117 trials monitored
See 235 trials at risk
2,245 trials monitored
See 115 trials at risk
and 1 more disease
The purpose of this study is to compare two ways to treat patients with Type 2 Diabetes, Standard Care or Case-Managed Care. In-Patient Standard Care is guided by the assigned cardiologist and Out-Patient Standard Care by the existing diabetes care givers. Case-Managed care involves a consult with an endocrinologist and counseling from a diabetic educator and a dietician.
Trial Details
NCT Number NCT00248352
Lead Sponsor Ottawa Heart Institute Research Corporation
Collaborators: Sanofi, Pfizer
Conditions
(from sponsor)
Diabetes Mellitus, Type 2, Coronary Disease
Related terms Chronic Disease, Coronary Artery Disease, Coronary Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2
Enrollment 169 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov